Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women

International Journal of Gynecological Cancer

Volumn 15, Issue 1, 2005, Pages 107-112

  Kang, S ^a,b   Jeon, Y T ^a,b   Kim, Jae Weon ^a,b   Park, N H ^a,b   Song, Yong Sang ^a,b   Kang, S B ^a,b   Lee, H P ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

E6 gene; HPV 16; Human papillomavirus; Polymorphism

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; DNA SEQUENCE; E6 GENE; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERUS CARCINOMA; VIRUS GENE; VIRUS GENOME;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; KOREA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

EID: 13244279456     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891x.2005.15010.x     Document Type: Article

References (19)

1. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-56.
2. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87: 796-802.
3. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
4. Phelps WC, Munger K, Yee CL, Barnes JA, Howley PM. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol 1992;66:2418-27.
5. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998;352:1441-2.
6. Matsumoto K, Yoshikawa H, Nakagawa S et al. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 2000;156:159-65.
7. Andersson S, Alemi M, Rylander E et al. Uneven distribution of HPV16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer 2000;83:307-10.
8. Zehbe I, Wilander E, Delius H, Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998;58:829-33.
9. Bontkes HJ, van Duin M, de Gruijl TD et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 1998;78:166-71.
10. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 1999;82:203-7.
11. Hu X, Guo Z, Tianyun P et al. HPV typing and HPV16 E6-sequence variations in synchronous lesions of cervical squamous-cell carcinoma from Swedish patients. Int J Cancer 1999;83:34-7.
12. Breitburd F, Coursaget P. Human papillomavirus vaccines. Semin Cancer Biol 1999;9:431-44.
13. Song YS, Kee SH, Kim JW et al. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol 1997;66:275-81.
14. Gregoire L, Arella M, Campione-Piccardo J, Lancaster WD. Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol 1989;27: 2660-5.
15. Evander M, Edlund K, Boden E et al. Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol 1992;30:987-92.
16. Kurvinen K, Yliskoski M, Saarikoski S, Syrjanen K, Syrjanen S. Variants of the long control region of human papillomavirus type 16. Eur J Cancer 2000;36:1402-10.
17. Zehbe I, Tachezy R, Mytilineos J et al. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 2001;94:711-6.
18. Kammer C, Tommasino M, Syrjanen S et al. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 2002;86:269-73.
19. Kim JW, Roh JW, Park NH, Song YS, Kang SB, Lee HP. Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women. Am J Obstet Gynecol 2001;184:55-8.